Added to YB: 2025-02-05
Pitch date: 2025-02-04
MREO [bullish]
Mereo BioPharma Group plc
-31.33%
current return
Author Info
Raging Bull Investments is a lawyer by background who shares actionable investment ideas on value opportunities with a catalyst. Sign up for the newsletter.
Company Info
Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally.
Market Cap
$281.6M
Pitch Price
$3.16
Price Target
6.30 (+190%)
Dividend
N/A
EV/EBITDA
-5.22
P/E
-5.60
EV/Sales
452.15
Sector
Biotechnology
Category
special_situation
Idea Update - 2/3/2025 - Mereo BioPharma Group plc
MREO: Setrusumab missed 1st interim P3, but 2nd interim in Q2 more likely. Q2 success could double stock. Alvelestat partnership delay concerning, but ODD may help. High PoS for 2nd interim setrusumab. Alvelestat deal or company sale still possible. Smart money and Rubric presence supportive.
Read full article (2 min)